These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36257066)

  • 1. Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.
    Beebe J; Josephraj S; Wang CJ; Danielson J; Cui Q; Huang C; Barlow L; Zhang RH; Zhang T; Nakshatri H; Dong Z; Li X; Liu JY; Zhang JT
    J Med Chem; 2022 Oct; 65(20):13681-13691. PubMed ID: 36257066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase.
    Wang CJ; Li D; Danielson JA; Zhang EH; Dong Z; Miller KD; Li L; Zhang JT; Liu JY
    Cancer Lett; 2021 Jul; 509():1-12. PubMed ID: 33813001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase.
    Fako VE; Wu X; Pflug B; Liu JY; Zhang JT
    J Med Chem; 2015 Jan; 58(2):778-84. PubMed ID: 25513712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.
    Yu M; Lee C; Wang M; Tannock IF
    Cancer Sci; 2015 Oct; 106(10):1438-47. PubMed ID: 26212113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer.
    Crous-Masó J; Palomeras S; Relat J; Camó C; Martínez-Garza Ú; Planas M; Feliu L; Puig T
    Molecules; 2018 May; 23(5):. PubMed ID: 29751678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma.
    Lupien LE; Dunkley EM; Maloy MJ; Lehner IB; Foisey MG; Ouellette ME; Lewis LD; Pooler DB; Kinlaw WB; Baures PW
    J Pharmacol Exp Ther; 2019 Oct; 371(1):171-185. PubMed ID: 31300609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.
    Sardesai SD; Thomas A; Gallagher C; Lynce F; Ottaviano YL; Ballinger TJ; Schneider BP; Storniolo AM; Bauchle A; Althouse SK; Perkins SM; Masters AR; Stratford RE; Dong Z; Liu JY; Zhang JT; Miller KD
    Clin Cancer Res; 2021 Nov; 27(21):5810-5817. PubMed ID: 34400413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer.
    Giró-Perafita A; Palomeras S; Lum DH; Blancafort A; Viñas G; Oliveras G; Pérez-Bueno F; Sarrats A; Welm AL; Puig T
    Clin Cancer Res; 2016 Sep; 22(18):4687-97. PubMed ID: 27106068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
    Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
    Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
    Goswami S; Sharma-Walia N
    Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition.
    Kao HW; Tsai KW; Lin WC
    Int J Med Sci; 2023; 20(6):717-724. PubMed ID: 37213670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis.
    Al-Bahlani S; Al-Lawati H; Al-Adawi M; Al-Abri N; Al-Dhahli B; Al-Adawi K
    Apoptosis; 2017 Jun; 22(6):865-876. PubMed ID: 28386750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole.
    Sahara S; Sugimoto M; Uotani T; Ichikawa H; Yamade M; Iwaizumi M; Yamada T; Osawa S; Sugimoto K; Umemura K; Miyajima H; Furuta T
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1129-37. PubMed ID: 24099474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.
    Ikemura K; Hamada Y; Kaya C; Enokiya T; Muraki Y; Nakahara H; Fujimoto H; Kobayashi T; Iwamoto T; Okuda M
    Drug Metab Dispos; 2016 Oct; 44(10):1543-9. PubMed ID: 27465369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lysosomal enzyme activities by proton pump inhibitors.
    Liu W; Baker SS; Trinidad J; Burlingame AL; Baker RD; Forte JG; Virtuoso LP; Egilmez NK; Zhu L
    J Gastroenterol; 2013 Dec; 48(12):1343-52. PubMed ID: 23478938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments.
    Dahabiyeh LA; Abu-Rish EY; Taha MO
    Pharmacol Rep; 2020 Apr; 72(2):435-442. PubMed ID: 32048247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.
    Rybniker J; Vocat A; Sala C; Busso P; Pojer F; Benjak A; Cole ST
    Nat Commun; 2015 Jul; 6():7659. PubMed ID: 26158909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction is responsible for fatty acid synthase inhibition-induced apoptosis in breast cancer cells by PdpaMn.
    Wang Q; Du X; Zhou B; Li J; Lu W; Chen Q; Gao J
    Biomed Pharmacother; 2017 Dec; 96():396-403. PubMed ID: 29031197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.